COMPANY
AnX Robotica
AnX Robotica is listed on ClinicalTrials.gov as the lead sponsor of 3 studies; the most recently updated is “NaviCam Patency Capsule to Verify Gastrointestinal Patency” (no phase, not yet recruiting), in Intestinal Stricture, Crohn Disease, NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy. From public records Source · Oct 12, 2026
Timeline
- Trial start Not phased (device or behavioral study): NaviCam Patency Capsule to Verify Gastrointestinal Patency source ↗
- Trial start —: A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a Ne source ↗
- FDA FDA 510(k) clearance: MotiliCap GI Monitoring System — K250493, May 21, 2025. Applicant at approval: Anx Robotica Corporation. source ↗
- Trial start Not phased (device or behavioral study): Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms source ↗
Upcoming milestones
- Dec 15, 2026 (ESTIMATED) · Not phased · NaviCam Patency Capsule to Verify Gastrointestinal Patency · NCT07649720
- Jun 15, 2028 (ESTIMATED) · · A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New A · NCT07633847
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07649720 | NaviCam Patency Capsule to Verify Gastrointestinal Patency | Not phased (device or behavioral study) | Not yet recruiting | Jun 15, 2026 | Dec 15, 2026 (estimated) |
| NCT07633847 | A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed. | Not listed | Not yet recruiting | Jun 15, 2026 | Jun 15, 2028 (estimated) |
| NCT04605302 | Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms | Not phased (device or behavioral study) | Completed | Feb 10, 2021 | Jun 30, 2021 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: MotiliCap GI Monitoring System — K250493, May 21, 2025. Applicant at approval: Anx Robotica Corporation. source ↗
Connect
See your connections at AnX Robotica on LinkedIn (search by name, results not checked)